ARX-EXEMESTANE exemestane 25mg tablet blister pack

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

exemestane, Quantity: 25 mg

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

Exemestane

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: colloidal anhydrous silica; sodium starch glycollate type A; hypromellose; mannitol; microcrystalline cellulose; magnesium stearate; crospovidone; polysorbate 80; titanium dioxide; macrogol 400

Stjórnsýsluleið:

Oral

Einingar í pakka:

90 Tablets, 30 Tablets, 15 Tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Exemestane is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . Exemestane is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Vörulýsing:

Visual Identification: White to off-white, round, biconvex film-coated tablets debossed with 'E25' on one side and plain on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Leyfisstaða:

Licence status A

Leyfisdagur:

2017-02-09